## Background: Pharyngocutaneous fistula is the most common complication following total laryngectomy. the present study was designed to determine the incidence and predisposing factors and to describe the management of the complication. ## Methods: The records of 246 consecutive patients who und
The incidence and etiology of postlaryngectomy pharyngocutaneous fistulae
β Scribed by Jukka A. Virtaniemi; Eero J. Kumpulainen; Pasi P. Hirvikoski; Risto T. Johansson; Veli-Matti Kosma
- Publisher
- John Wiley and Sons
- Year
- 2000
- Tongue
- English
- Weight
- 62 KB
- Volume
- 23
- Category
- Article
- ISSN
- 1043-3074
No coin nor oath required. For personal study only.
β¦ Synopsis
Background. The pharyngocutaneous fistula is troublesome complication after total laryngectomy. Despite a large number of studies, there is still disagreement on factors predisposing to this complication.
Methods. A retrospective analysis of pharyngocutaneous fistulas in 133 patients in whom total laryngectomy was performed.
Results. Fistulas were found in 15% of the patients. Spontaneous closure was noted in 80%. Simultaneous laryngectomy and partial pharyngectomy or neck dissection increased the risk of fistula formation. Preoperative irradiation, short interval between radiotherapy and operation, and cobalt/roentgen radiation instead of photons predispose to this complication. The fistulas appeared earlier, and the sizes of fistulas were significantly larger in patients with previous irradiation than those in patients with no preoperative irradiation.
Conclusions. Postoperative pharyngocutaneous fistulas significantly increase patients' morbidity and hospital stay. Good surgical technique and postoperative treatment should be paid attention to patients with an increased risk of pharyngocutaneous fistula formation.
π SIMILAR VOLUMES
## Abstract Pharyngocutaneous fistulas (PCFs) following total laryngectomy is a common complication. The standard therapy is conservative management, and if this is not successful, surgical closure. There is a group of patients with limited survival chance who have small PCFs. In these patients who
## Abstract ## Background. We report on the contribution of recombinant plateletβderived growth factorβBB (becaplermin) in treating recalcitrant postlaryngectomy fistulas in two patients with head and neck cancer. ## Methods. Topical becaplermin was applied daily, with periodic wound assessment